Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 154Unknown 56Terminated 10Withdrawn 5Recruiting 4Active not recruiting 3Enrolling by invitation 2Not yet recruiting 1

Sponsor Class

OTHER 57INDUSTRY 18NETWORK 5NIH 3OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2

Conditions

Multiple Myeloma 38Lymphoma 37Ovarian Neoplasms 25Lung Neoplasms 25Melanoma 23Neoplasm Metastasis 21Hematologic Neoplasms 21Carcinoma, Non-Small-Cell Lung 21Leukemia, Myeloid, Acute 20Fallopian Tube Neoplasms 19Breast Neoplasms 18Prostatic Neoplasms 17Glioma 17Sarcoma 14Colorectal Neoplasms 14Carcinoma, Renal Cell 14Uterine Cervical Neoplasms 12Neoplasms 12Urinary Bladder Neoplasms 11Small Cell Lung Carcinoma 11Lymphoma, Non-Hodgkin 11Leukemia, Lymphocytic, Chronic, B-Cell 11Glioblastoma 11Triple Negative Breast Neoplasms 10Pancreatic Neoplasms 10Medulloblastoma 10Wilms Tumor 9Sarcoma, Ewing 9Rhabdomyosarcoma 9Rhabdoid Tumor 9

Interventions

ibrutinib 1Rituximab 1Magnetic Resonance Imaging 1Exercise Test 1Electrocardiography 1Echocardiography 1Cladribine 1Caves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × NIH × Leukemia × Clear all
NCT00039676 2026-05-01

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

National Institutes of Health Clinical Center (CC)

Active not recruiting
1,836 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01500733 2026-04-28

PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
86 enrolled 10 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphoid, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00923013 2025-08-08

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
175 enrolled 16 charts
Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡